key: cord-0811885-lueujn3b
authors: Cocco, P.; Meloni, F.; Coratza, A.; Schirru, D.; Campagna, M.; De Matteis, S.
title: Vaccination against seasonal influenza and socio-economic and environmental factors as determinants of the geographic variation of COVID-19 incidence and mortality in the Italian elderly
date: 2020-12-02
journal: Prev Med
DOI: 10.1016/j.ypmed.2020.106351
sha: 1da6be85c139486be4ccdfdd97775acbae96d813
doc_id: 811885
cord_uid: lueujn3b

Background A possible protective effect of seasonal influenza vaccination against the spread of the COVID-19 epidemic has been suggested. Methods We used publicly available data bases to explore the hypothesis as well as the effect of multiple social and environmental factors in the 20 Italian regions. Results Our results suggest that vaccination against seasonal influenza might beneficially impact on incidence and severity of the novel corona virus epidemic. Population density and vehicular traffic were also moderately associated with cumulative incidence of COVID-19. None of the other variables we considered showed an effect on cumulative incidence, case fatality rate or mortality from COVID-19. Conclusions Extending influenza vaccination coverage particularly among the elderly, vulnerable individuals with specific chronic medical conditions, health care workers, and workers in other essential services, early in the upcoming 2020 influenza season, might help reduce the health impact of a second epidemic wave of COVID-19.

The 2019-2020 novel corona virus SARS-CoV-2 pandemic hit at different times, with variable force worldwide. Reasons for such geographical variation in virulence are not clearly understood; various factors have been suggested, including environmental pollution (1), temperature, humidity, UV index (2, 3) , and smoking (4) . In the first quarter of year 2020, Italy has been the first and one of the worst hit western countries, with COVID- 19 showing a peculiar, southward decreasing trend in cumulative incidence and mortality (5) . Also, consistently with what reported in other countries, almost 60% deaths occurred among the elderly living in retirement homes (5) , where social contact is considered a benefit; therefore, vulnerable subjects were not appropriately isolated from the rising epidemic, and the staff taking care of them often acted as carrier.

One hundred fifteen cases of co-occurrence of influenza A and COVID-19 have been described in Wuhan, China (6) , and several clinical reports have described the same co-occurrence worldwide (7) . A survey conducted in Italy between April and June 2020 reported a significant reduction in risk of SARS-CoV-2 naso-pharyngeal swab test positivity associated with previous influenza and pneumococcal vaccination among younger subjects. The statistical power was not sufficient to exclude chance as the determinant of the same size reduction in risk observed among subjects aged ≥65 years (8) . On the other hand, a direct correlation between influenza (H1N1) vaccination status and the attack rate of COVID-19 as a measure of outbreak severity was observed in 34 world countries, limited to the 15 days between 27 February and 12 March 2020 (9) which the author interpreted as suggestive of influenza vaccine possibly favouring COVID-19 respiratory tract infections, due to vaccine interference. However, another cross-sectional survey, conducted among the U.S.A. military in 2019, observed that influenza vaccination conferred a reduction in risk for several other influenza and parainfluenza infections, while vaccine interference showed its effects in increasing risk of coronavirus and human metapneumovirus infection (10) .

We explored the relationship between vaccination against seasonal influenza in subjects aged ≥65 years and the concurrent effect of multiple socio-economic and environmental factors and COVID-19 cumulative incidence, cumulative death rate, and case fatality rate in the 20 Italian regions.

We used publicly available online resources to extract data on the following socio-economic and environmental variables for each of the 20 Italian regions: average number of household residents (100 x residents/m 2 ), average per capita income (€/1000), deprivation index (modified from http://istat.it), circulating vehicles per 100 residents (www.comuni-italiani.it/statistiche/), average temperature in March in the main urban area of the region in the Celsius scale (https://www.ilmeteo.it/portale/archivio-meteo/), and population density (https://www.tuttitalia.it/regioni/densita/). The Italian National Institute of Statistics (ISTAT) deprivation index combines several characteristics, such as educational level, percent of unemployed, housing and familiar conditions, to express the level of social disadvantage of a given population (11). As the ISTAT deprivation index varies around zero, for the purposes of our analysis, we modified it by eliminating the negative values through adding an equal quantity to each regional value, corresponding to 1+ the lowest negative value, so to have the lowest representing the wealthiest region. We extracted the 2019-2020 seasonal influenza vaccination rates among the resident population aged ≥ 65 by region from the Italian National Institute of Health (ISS) web site (https://www.epicentro.iss.it/influenza/coperture-vaccinali). ISS was also the source for the number of total COVID-19 incident cases (all ages, both genders), number of COVID-19 deaths in March 2020 by region, age, and gender, and for the COVID-19 case fatality rate (deaths/100 diagnoses, all ages, both genders) by region (https://www.epicentro.iss.it/ en/coronavirus/sars-cov-2-integrated-surveillance-data). The resident population of each region aged 65 years or older was extracted from the ISTAT web site (https://www.istat.it/). Seasonal influenza vaccination rates among the Italian population in the winter 2019-2020 were available by region for the total population aged ≥65, but not gender stratified. Also, COVID-19 incidence and case fatality rate were available for the total population at the regional level; however, as 91% of incident cases, and 94% of deaths from COVID-19 occurred among subjects aged ≥65, we used the overall cumulative incidence and case fatality rate as proxies for mortality among the elderly. Also, based on the nationwide proportion of COVID-19 cases aged ≥65 years, we estimated the number of incident cases among elderly by region, and the cumulative incidence rate in the corresponding age group. Of note, we could not find data on the number of residents in retirement homes for the elderly and disabled, nor on the prevalence of occupational groups at higher risk, such as healthcare workers by region.

We first conducted univariate linear regression analyses to assess the relationship between seasonal influenza vaccination rate, and COVID-19 cumulative incidence, cumulative deaths, and case-fatality rate from the date of registration of the first case through 31 March 2020. This period was selected because it included the phase of logarithmic growth of the epidemic curve in Italy. We used the Pearson's correlation statistic to test the chance probability associated with the observed regression line.

Based on the available data, we calculated the cumulative COVID-19 incidence (1,000 x number of cases diagnosed with COVID-19 among subjects aged ≥ 65 years/ total residents aged ≥ 65 years as of 1 January 2020 ), and the cumulative COVID-19 death rate among the population aged ≥ 65 years (10,000 x number of deaths among subjects aged ≥ 65 years /total residents aged ≥ 65 years as of 1 January 2020) by Italian region. We used multiple regression analysis to predict COVID-19 cumulative incidence, cumulative death rate, and case fatality rate, as a function of average number of household residents, average per capita income, deprivation index, circulating vehicles, average temperature in March, population density, and seasonal influenza vaccination rate among subjects aged ≥ 65. We followed a stepwise backward procedure, and retained the variables included in the best fitting model, as indicated by the adjusted R 2 value.

We used SPSS® 20.0 to conduct the analysis. Figure 1 shows significant negative association between COVID-19 cumulative incidence (a), cumulative death rate (b), and case fatality rate (c) and the respective seasonal influenza vaccination rates among the population aged ≥65 years in the 20 Italian regions. The inverse trend by vaccination rate did not change after replacing the estimated cumulative incidence in the elderly with that over the total resident population (r = 0.546, p = 0.006).

We explored a few potentially contributing factors from environmental and socio-economic origin with multiple regression analysis. Table 1 shows the correlation matrix of the selected predictive variables. As expected, average income, crowding index, and deprivation index showed a strong reciprocal correlation. Average income and crowding index were not significant predictors of COVID-19 cumulative incidence in the multiple regression analysis, and therefore these variables are not included, and only deprivation index is retained in the best fitting regression models, which results are shown in Table 2 . After the reciprocal adjustments, vaccination rate against seasonal influenza still showed an inverse association of borderline significance, which was weakened, but still visible, when using the crude cumulative incidence calculated over the whole resident population. The association was stronger with cumulative death rate, and severity of the disease, as represented by the case fatality rate. Population density and vehicular traffic increased cumulative incidence of COVID-19 among the elderly, perhaps by reducing social distance and increasing the susceptibility of the respiratory system already affected by the particulate emissions in the atmosphere. Deprivation index was instead inversely associated with cumulative incidence of COVID-19, which might be suggestive of an increased risk among the wealthier, possibly because of a more intense social activity. Contrasting previously reported effect of a higher average temperature in reducing the impact of the COVID-19 epidemic (2,3), average temperature did not affect any of the outcomes, and circulating vehicles did not affect either cumulative mortality or case fatality rate.

Our results suggest that vaccination against seasonal influenza might beneficially impact on incidence and severity of the novel corona virus epidemic in subjects aged 65 years or older.

Our findings are in agreement with a recent ecological study that evaluated this hypothesis in Italy, but it did not have access to the most recent 2019-2020 regional influenza vaccination coverage rate (12) ; therefore, our work confirms and extends these results.

Long lasting cross-protection has been described in the elderly from pre-existing antibodies against different H1N1 viral strains or previous contacts with the same strain (13) (14) (15) . SARS-CoV-2 genomic sequence has been recently J o u r n a l P r e -p r o o f characterized as closely related to two SARS-like coronaviruses, with a similar receptor-binding domain structure, and some amino acid variation at key residues (16), allowing its identification as a new human-infecting b coronavirus. However, the pathogenesis of influenza and SARS-CoV-2 viruses requires similar hemagglutinin-esterase proteins (17) ; both share spike protein features with class 1 viral membrane fusion proteins (18, 19) ; and, alike SARS-CoV-2, influenza A viruses also link to the ACE-2 receptors in the lung (20) .

Although suggestive, the circumstantial evidence and the results of our ecological analysis do not prove that seasonal influenza vaccination would prevent COVID-19 occurrence by inducing antibodies against common specific antigens. First, we conducted an exploratory analysis of public data on influenza vaccination coverage, which were available for subjects aged ≥ 65 years only; therefore, we could not explore the suggested age-related varying response to viral infections. Second, the so-called ecological fallacy is a main problem limiting the interpretation of the ecological studies, as the geographic area and not the individual is the unit of measurement, and all subjects within the same area are considered equally exposed to the same factors, while we could not assess whether the within region variance in exposure to each factor would be smaller, similar, or even greater than the between regions variance. Therefore, it is never justified interpreting such results in terms of the individuals composing the population of the area (21) . Third, the outcomes we explored refer to the ≥ 65 year old population segment, and not to the whole population, while the socioeconomic and environmental indicators we used refer to the total population of each region. This is a further reason for suggesting caution in interpreting our findings. Finally, we cannot exclude that possible confounding, due to factors associated with influenza vaccination other than those selected, might have affected our results. For instance, as influenza vaccination is a personal choice, it is quite plausible that the resulting benefits against other infections would result from a generic healthier lifestyle of the persons who choose to be vaccinated in respect to those who did not, and not from the vaccine itself. Still, the U.S. Centers for Disease Control recommends vaccination against seasonal influenza for poultry workers to prevent avian flu (22) , and a few reports suggested (6, 7) , that preventing seasonal influenza via vaccination would also avoid superimposing its effects on COVID-19, thus worsening the prognosis. On the other hand, mathematical models suggest that efforts in extending public health measures against seasonal influenza would prevent overburdening the healthcare system from co-occurrence of respiratory outbreaks, and shortage of laboratory equipment and treatment devices (23). For instance, beneficial effects might result from excluding influenza in the differential diagnosis of COVID-19-like symptomatic cases, which would restrict the number of cases requiring a deeper diagnostic work up, so lightening the burden on the healthcare system capacity.

Further formal observational epidemiological analyses are warranted to test this hypothesis. Nonetheless, 1) a specific vaccine against SARS-CoV-2 would not be expected to become available to the general population worldwide in a short time; and 2) benefits and no harm would result from a more extensive influenza vaccination coverage in the general population worldwide. Besides social distancing and use of face masks, enforcing the WHO recommendation on the use of seasonal influenza vaccination (24), and extending the coverage particularly among the elderly, vulnerable individuals with specific chronic medical conditions, health care workers, and workers in other essential services, early in the upcoming 2020 influenza season, might help reduce the health impact of a second epidemic wave of COVID-19. 

Correlation between environmental pollution indicators and COVID-19 pandemic: A brief study in Californian context

Effects of Temperature Variation and Humidity on the Death of COVID-19 in Wuhan

On the global trends and spread of the COVID-19 outbreak: preliminary assessment of the potential relation between location-specific temperature and UV index

COVID-19 and smoking: A systematic review of the evidence

COVID-19 integrated surveillance: key national data

The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan

Co-infection with Influenza A and COVID-19

The association between influenza and pneumococcal vaccinations and Sars-CoV-2 infection: data from the EPICOVID19 web based survey

Association between influenza vaccination rates and SARS-CoV-2 outbreak infection rates in OECD countries

Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season

Relationship between Influenza Vaccination Coverage Rate and COVID-19 Outbreak: An Italian Ecological Study. Vaccines (Basel)

Investigating the Legacy of the 1918 Influenza Pandemic in Age-Related Seroepidemiology and Immune Responses to Subsequent Influenza A(H1N1) Viruses Through a Structural Equation Model

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses

Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution

Structure, Function, and Evolution of Coronavirus Spike Proteins

Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom

The ecological fallacy

US Centers for Disease Control and Prevention. Prevention and treatment of avian influenza A viruses in people